New Generation Vaccines

The Role of Basic Immunology

  • Gregory Gregoriadis
  • Brenda McCormack
  • Anthony C. Allison
  • George Poste
Book

Part of the NATO ASI Series book series (NSSA, volume 261)

Table of contents

  1. Front Matter
    Pages i-viii
    PDF
  2. Dendritic Cells: Nature’s Adjuvants
    Jonathan M. Austyn
    Pages 1-10
  3. The Multiple Accessory Cell Concept: Its Relevance to the Development of Adjuvants and Vaccines
    Nico Van Rooijen
    Pages 11-22
  4. Synthetic Peptides and the Role of T-Helper Cell Determinants
    M. J. Francis
    Pages 23-32
  5. Carriers for Peptides: Theories and Technology
    M. J. Francis
    Pages 33-42
  6. Co-Entrapment of T-Cell and B-Cell Peptides in Liposomes Overcomes Genetic Restriction in Mice and Induces Immunological Memory
    Gregory Gregoriadis, Zhen Wang, Michael J. Francis
    Pages 43-49
  7. Preparation and Characterization of Stable Liposomal Hepatitis B Vaccine
    D. Diminsky, Z. Even-Chen, Y. Barenholz
    Pages 51-59
  8. Initiation of Immune Response with ISCOM
    B. Morein, M. Villacres-Eriksson, L. Åkerblom, K. Lövgren
    Pages 61-72
  9. Nanoparticles as Potent Adjuvants for Vaccines
    Jorg Kreuter
    Pages 73-81
  10. Optimization of Carriers and Adjuvants a Model Study Using Semliki Forest Virus Infection of Mice
    A. Snijders, I. M. Fernandez, C. A. Kraaijeveld, H. Snippe
    Pages 83-100
  11. Immunotargeting as an Adjuvant-Independent Subunit Vaccine Design Option
    Danna L. Skea, Brian H. Barber
    Pages 101-110
  12. BCG Vaccine: The Next Generation of Targeted Drug Delivery Systems
    M. J. Groves, Yan Lou, M. E. Klegerman
    Pages 111-116
  13. Significance of Virulence Factors and Immuno-Evasion for the Design of Gene-Deleted Herpesvirus Marker Vaccines
    Saul Kit
    Pages 117-129
  14. Eradication of Sylvatic Rabies Using a Live Recombinant Vaccinia-Rabies Vaccine
    Marie Paule Kieny, Bernard Brochier, Paul-Pierre Pastoret
    Pages 131-138
  15. Vaccination of Wildlife: The Role of Recombinant Poxvirus Vaccines
    E. Paul J. Gibbs
    Pages 139-148
  16. Recombinant Protein Antigens with ‘Built-in’ Adjuvanticity
    P. Ghiara, L. Villa, R. Rappuoli, S. Gonfloni, L. Castagnoli, G. Cesareni
    Pages 149-154
  17. Vaccination against Malaria; The Anti-Disease Concept
    J. H. L. Playfair, J. Taverne, Caw Bate
    Pages 155-162
  18. Progress in the Development of Epstein-Barr Virus Vaccines
    Andrew J. Morgan
    Pages 163-173
  19. Requirements for Induction of Semliki Forest Virus Neutralizing Antibodies by a Non-Internal Image Monoclonal Antibody
    Cornelis A. Kraaijeveld, Tom A. M. Oosterlaken, Harm Snippe
    Pages 175-183
  20. Polysaccharide Vaccines
    M. R. Lifely
    Pages 185-199

About this book

Keywords

Antigen biology biotechnology cell biology diseases hepatitis infectious disease protein proteins research vaccine virus

Editors and affiliations

  • Gregory Gregoriadis
    • 1
  • Brenda McCormack
    • 1
  • Anthony C. Allison
    • 2
  • George Poste
    • 3
  1. 1.School of PharmacyUniversity of LondonLondonUK
  2. 2.Syntex ResearchPalo AltoUSA
  3. 3.SmithKline Beecham PharmaceuticalsSurreyUK

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4615-2948-4
  • Copyright Information Plenum Press, New York 1993
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-6281-4
  • Online ISBN 978-1-4615-2948-4
  • About this book